EUVIMEDEUVIMED entdecken
Crossref

LncRNA DLX6-AS1 Regulates the Pathological Process Related to Alzheimer’s Disease via miR-204-5p

Minggang Jiang, Yang Lin, Liping Wang, Kaiyun Ou

NeuroMolecular Medicine · 29.07.2026 · 28 (1)

DOI: 10.1007/s12017-026-08941-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift NeuroMolecular Medicine, online erschienen am 29.07.2026. Verfasst von Minggang Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, The Fourth People's Hospital of Jiande, 311612, Hangzhou, China. Hauptthemen laut MEDLINE: Alzheimer Disease, MicroRNAs, RNA, Long Noncoding, Homeodomain Proteins. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a neurodegenerative disorder causing progressive neuronal damage. Incidence rises with age, and early diagnosis is difficult. This study examined DLX6-AS1 clinical relevance and regulatory mechanism in AD, and its interaction with miR-204-5p in AD pathology. It offers new insights into early diagnosis and treatment. A total of 133 AD patients and 105 healthy controls were selected. Their serum levels of DLX6-AS1 and miR-204-5p were analyzed using quantitative polymerase chain reaction. β-amyloid (Aβ)_1–42-induced SH-SY5Y neuronal injury and okadaic acid (OA)-induced Neuro-2a tau abnormal phosphorylation models were constructed. The role/function of DLX6-AS1/miR-204-5p axis was then investigated using cell counting kit-8, flow cytometry, western blotting, enzyme-linked immunosorbent assay and a dual-luciferase reporter gene assay. AD patients had higher serum DLX6-AS1 and lower miR-204-5p levels. DLX6-AS1 showed an AUC of 0.838 for AD diagnosis. DLX6-AS1 levels were negatively associated with cognitive function, brain structural integrity, and benign pathology—and positively associated with disease severity, functional impairment, and pathological markers. In AD cell models, DLX6-AS1 was upregulated. Silencing it promoted cell proliferation, reduced apoptosis and oxidative stress, improved mitochondrial and synaptic function, decreased tau phosphorylation, and enhanced microtubule stability and axonal transport. Dual-luciferase assays confirmed direct binding between DLX6-AS1 and miR-204-5p. Co-inhibition reversed the protective effects of DLX6-AS1 silencing. Serum DLX6-AS1 is a potential biomarker for early diagnosis and assessment of AD. It regulates Aβ-induced neuronal damage and tau phosphorylation by targeting miR-204-5p, offering a new mechanism target for AD molecular therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMicroRNAsRNA, Long NoncodingHomeodomain ProteinsHumanstau ProteinsFemaleMaleAmyloid beta-PeptidesPhosphorylationCell Line, TumorAgedAnimalsPeptide FragmentsAged, 80 and overMiceBrain

Stichwörter der Autor:innen

Alzheimer’s diseaseLncRNANeuron damageTau phosphorylationmiRNA

Substanzen

MicroRNAstau ProteinsMIR204, humanAmyloid beta-PeptidesRNA, Long NoncodingDLX6 protein, humanHomeodomain Proteinsamyloid beta-protein (1-42)Peptide FragmentsMAPT protein, human

Autor:innen und Institutionen

  • Department of Psychiatry, The Fourth People's Hospital of Jiande, 311612, Hangzhou, China.
  • Department of Neurology, Baotou City Central Hospital, 014040, Baotou, Inner Mongolia, China.
  • Department of Neurology, The Air Force Hospital of Southern Theater Command, PLA, 510602, Guangzhou, Guangdong, China.
  • Department of Neurology, The People's Hospital of Laibin, No. 159 East Pangu Avenue, 546100, Laibin, Guangxi, China. Oukaiyundr@163.com.

Zitieren

APA

Jiang, M., Lin, Y., Wang, L., & Ou, K. (2026). LncRNA DLX6-AS1 Regulates the Pathological Process Related to Alzheimer’s Disease via miR-204-5p. NeuroMolecular Medicine, 28(1). https://doi.org/10.1007/s12017-026-08941-w

Vancouver

Jiang M, Lin Y, Wang L, Ou K. LncRNA DLX6-AS1 Regulates the Pathological Process Related to Alzheimer’s Disease via miR-204-5p. NeuroMolecular Medicine. 2026;28(1). doi:10.1007/s12017-026-08941-w

BibTeX
@article{Jiang2026,
  author = {Jiang, Minggang and Lin, Yang and Wang, Liping and Ou, Kaiyun},
  title = {LncRNA DLX6-AS1 Regulates the Pathological Process Related to Alzheimer’s Disease via miR-204-5p},
  journal = {NeuroMolecular Medicine},
  year = {2026},
  volume = {28},
  number = {1},
  doi = {10.1007/s12017-026-08941-w}
}
Kostenlos starten →